You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Sophocarpidine (CAS:519-02-8) Market Research Report 2021 Professional Edition

Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.
Market Analysis and Insights: Global Sophocarpidine (CAS?¦?519-02-8) Market
The global Sophocarpidine (CAS?¦?519-02-8) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Sophocarpidine (CAS?¦?519-02-8) Scope and Segment
The global Sophocarpidine (CAS?¦?519-02-8) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sophocarpidine (CAS?¦?519-02-8) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
High Purity
Low Purity
By the end users/application, this report covers the following segments
Pharmaceuticals
Pesticides
Others
Competitive Landscape:
The report provides a list of all the key players in the Sophocarpidine (CAS?¦?519-02-8) market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Sophocarpidine (CAS?¦?519-02-8) key manufacturers in this market include:
Fujie Pharmaceutical
QHL Pharma
Select Botanical
Indena
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Hubei Zhongliao Chemical Co., LTD
1 Sophocarpidine (CAS?¦?519-02-8) Market Overview
1.1 Sophocarpidine (CAS?¦?519-02-8) Product Overview
1.2 Sophocarpidine (CAS?¦?519-02-8) Market Segment by Type
1.2.1 High Purity
1.2.2 Low Purity
1.3 Global Sophocarpidine (CAS?¦?519-02-8) Market Size by Type
1.3.1 Global Sophocarpidine (CAS?¦?519-02-8) Market Size Overview by Type (2016-2027)
1.3.2 Global Sophocarpidine (CAS?¦?519-02-8) Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Sophocarpidine (CAS?¦?519-02-8) Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Sophocarpidine (CAS?¦?519-02-8) Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Sophocarpidine (CAS?¦?519-02-8) Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Type (2016-2021)
1.4.2 Europe Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Type (2016-2021)

2 Global Sophocarpidine (CAS?¦?519-02-8) Market Competition by Company
2.1 Global Top Players by Sophocarpidine (CAS?¦?519-02-8) Sales (2016-2021)
2.2 Global Top Players by Sophocarpidine (CAS?¦?519-02-8) Revenue (2016-2021)
2.3 Global Top Players Sophocarpidine (CAS?¦?519-02-8) Price (2016-2021)
2.4 Global Top Manufacturers Sophocarpidine (CAS?¦?519-02-8) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sophocarpidine (CAS?¦?519-02-8) Market Competitive Situation and Trends
2.5.1 Sophocarpidine (CAS?¦?519-02-8) Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Sophocarpidine (CAS?¦?519-02-8) Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sophocarpidine (CAS?¦?519-02-8) as of 2020)
2.7 Date of Key Manufacturers Enter into Sophocarpidine (CAS?¦?519-02-8) Market
2.8 Key Manufacturers Sophocarpidine (CAS?¦?519-02-8) Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Sophocarpidine (CAS?¦?519-02-8) Status and Outlook by Region
3.1 Global Sophocarpidine (CAS?¦?519-02-8) Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Sophocarpidine (CAS?¦?519-02-8) Historic Market Size by Region
3.2.1 Global Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Region (2016-2021)
3.2.2 Global Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Region (2016-2021)
3.2.3 Global Sophocarpidine (CAS?¦?519-02-8) Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Sophocarpidine (CAS?¦?519-02-8) Forecasted Market Size by Region
3.3.1 Global Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Region (2022-2027)
3.3.2 Global Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Region (2022-2027)
3.3.3 Global Sophocarpidine (CAS?¦?519-02-8) Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Sophocarpidine (CAS?¦?519-02-8) by Application
4.1 Sophocarpidine (CAS?¦?519-02-8) Market Segment by Application
4.1.1 Pharmaceuticals
4.1.2 Pesticides
4.1.3 Others
4.2 Global Sophocarpidine (CAS?¦?519-02-8) Market Size by Application
4.2.1 Global Sophocarpidine (CAS?¦?519-02-8) Market Size Overview by Application (2016-2027)
4.2.2 Global Sophocarpidine (CAS?¦?519-02-8) Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Sophocarpidine (CAS?¦?519-02-8) Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Sophocarpidine (CAS?¦?519-02-8) Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Sophocarpidine (CAS?¦?519-02-8) Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Application (2016-2021)
4.3.2 Europe Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Sophocarpidine (CAS?¦?519-02-8) Sales Breakdown by Application (2016-2021)

5 North America Sophocarpidine (CAS?¦?519-02-8) by Country
5.1 North America Sophocarpidine (CAS?¦?519-02-8) Historic Market Size by Country
5.1.1 North America Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Country (2016-2021)
5.1.2 North America Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Country (2016-2021)
5.2 North America Sophocarpidine (CAS?¦?519-02-8) Forecasted Market Size by Country
5.2.1 North America Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Country (2022-2027)
5.2.2 North America Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Country (2022-2027)

6 Europe Sophocarpidine (CAS?¦?519-02-8) by Country
6.1 Europe Sophocarpidine (CAS?¦?519-02-8) Historic Market Size by Country
6.1.1 Europe Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Country (2016-2021)
6.1.2 Europe Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Country (2016-2021)
6.2 Europe Sophocarpidine (CAS?¦?519-02-8) Forecasted Market Size by Country
6.2.1 Europe Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Country (2022-2027)
6.2.2 Europe Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Country (2022-2027)

7 Asia-Pacific Sophocarpidine (CAS?¦?519-02-8) by Region
7.1 Asia-Pacific Sophocarpidine (CAS?¦?519-02-8) Historic Market Size by Region
7.1.1 Asia-Pacific Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Sophocarpidine (CAS?¦?519-02-8) Forecasted Market Size by Region
7.2.1 Asia-Pacific Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Region (2022-2027)

8 Latin America Sophocarpidine (CAS?¦?519-02-8) by Country
8.1 Latin America Sophocarpidine (CAS?¦?519-02-8) Historic Market Size by Country
8.1.1 Latin America Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Country (2016-2021)
8.1.2 Latin America Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Country (2016-2021)
8.2 Latin America Sophocarpidine (CAS?¦?519-02-8) Forecasted Market Size by Country
8.2.1 Latin America Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Country (2022-2027)
8.2.2 Latin America Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Country (2022-2027)

9 Middle East and Africa Sophocarpidine (CAS?¦?519-02-8) by Country
9.1 Middle East and Africa Sophocarpidine (CAS?¦?519-02-8) Historic Market Size by Country
9.1.1 Middle East and Africa Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Sophocarpidine (CAS?¦?519-02-8) Forecasted Market Size by Country
9.2.1 Middle East and Africa Sophocarpidine (CAS?¦?519-02-8) Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Sophocarpidine (CAS?¦?519-02-8) Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Sophocarpidine (CAS?¦?519-02-8) Business
10.1 Fujie Pharmaceutical
10.1.1 Fujie Pharmaceutical Corporation Information
10.1.2 Fujie Pharmaceutical Introduction and Business Overview
10.1.3 Fujie Pharmaceutical Sophocarpidine (CAS?¦?519-02-8) Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Fujie Pharmaceutical Sophocarpidine (CAS?¦?519-02-8) Products Offered
10.1.5 Fujie Pharmaceutical Recent Development
10.2 QHL Pharma
10.2.1 QHL Pharma Corporation Information
10.2.2 QHL Pharma Introduction and Business Overview
10.2.3 QHL Pharma Sophocarpidine (CAS?¦?519-02-8) Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Fujie Pharmaceutical Sophocarpidine (CAS?¦?519-02-8) Products Offered
10.2.5 QHL Pharma Recent Development
10.3 Select Botanical
10.3.1 Select Botanical Corporation Information
10.3.2 Select Botanical Introduction and Business Overview
10.3.3 Select Botanical Sophocarpidine (CAS?¦?519-02-8) Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Select Botanical Sophocarpidine (CAS?¦?519-02-8) Products Offered
10.3.5 Select Botanical Recent Development
10.4 Indena
10.4.1 Indena Corporation Information
10.4.2 Indena Introduction and Business Overview
10.4.3 Indena Sophocarpidine (CAS?¦?519-02-8) Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Indena Sophocarpidine (CAS?¦?519-02-8) Products Offered
10.4.5 Indena Recent Development
10.5 TIANSHAN Pharmaceuticals
10.5.1 TIANSHAN Pharmaceuticals Corporation Information
10.5.2 TIANSHAN Pharmaceuticals Introduction and Business Overview
10.5.3 TIANSHAN Pharmaceuticals Sophocarpidine (CAS?¦?519-02-8) Sales, Revenue and Gross Margin (2016-2021)
10.5.4 TIANSHAN Pharmaceuticals Sophocarpidine (CAS?¦?519-02-8) Products Offered
10.5.5 TIANSHAN Pharmaceuticals Recent Development
10.6 Selco Wirkstoffe Vertriebs GmbH
10.6.1 Selco Wirkstoffe Vertriebs GmbH Corporation Information
10.6.2 Selco Wirkstoffe Vertriebs GmbH Introduction and Business Overview
10.6.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS?¦?519-02-8) Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS?¦?519-02-8) Products Offered
10.6.5 Selco Wirkstoffe Vertriebs GmbH Recent Development
10.7 Jiangsu Tiansheng Pharmaceutical
10.7.1 Jiangsu Tiansheng Pharmaceutical Corporation Information
10.7.2 Jiangsu Tiansheng Pharmaceutical Introduction and Business Overview
10.7.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS?¦?519-02-8) Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS?¦?519-02-8) Products Offered
10.7.5 Jiangsu Tiansheng Pharmaceutical Recent Development
10.8 Tiansheng Pharmaceutical
10.8.1 Tiansheng Pharmaceutical Corporation Information
10.8.2 Tiansheng Pharmaceutical Introduction and Business Overview
10.8.3 Tiansheng Pharmaceutical Sophocarpidine (CAS?¦?519-02-8) Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Tiansheng Pharmaceutical Sophocarpidine (CAS?¦?519-02-8) Products Offered
10.8.5 Tiansheng Pharmaceutical Recent Development
10.9 Hubei Zhongliao Chemical Co., LTD
10.9.1 Hubei Zhongliao Chemical Co., LTD Corporation Information
10.9.2 Hubei Zhongliao Chemical Co., LTD Introduction and Business Overview
10.9.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS?¦?519-02-8) Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS?¦?519-02-8) Products Offered
10.9.5 Hubei Zhongliao Chemical Co., LTD Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sophocarpidine (CAS?¦?519-02-8) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sophocarpidine (CAS?¦?519-02-8) Industrial Chain Analysis
11.4 Sophocarpidine (CAS?¦?519-02-8) Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sophocarpidine (CAS?¦?519-02-8) Distributors
12.3 Sophocarpidine (CAS?¦?519-02-8) Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140